#United States #Clinical Trials #Conshohocken #Suvoda #Greenphire

Suvoda's Innovative Approach to Clinical Trials

In 2025, Suvoda made substantial advancements in clinical trial technology, revolutionizing the patient experience and streamlining operations for trial sites. A key pivotal moment for the company was the successful merger with Greenphire, which strengthened its capabilities to address ongoing operational challenges within clinical trials from a unified perspective. This strategic fusion laid the foundation for a more consolidated approach to clinical trials, allowing Suvoda to enhance its offerings significantly.

CEO Jagath Wanninayake emphasized the milestone achieved by Suvoda in the past year, stating, "The past twelve months have marked significant progress for Suvoda. Our teams have worked diligently to merge two strong companies and deliver new capabilities that reflect the real needs of patients and sites. As we enter 2026, our focus is on helping sponsors and sites manage their clinical trials with clarity while providing patients with a seamless and supportive experience."

Enhancing the Patient Journey

A standout achievement was the launch of Suvoda’s patient app, which showcases how a unified platform can greatly improve patients' experiences in clinical trials. This app integrates electronic clinical outcome assessment (eCOA) questionnaires, patient payments, appointment reminders, and scheduling features into a user-friendly interface accessible on patients' personal devices. The function helps keep participants engaged and eases the administrative burden on busy sites.

Leveraging AI to Alleviate Administrative Burdens

Suvoda also took major steps to simplify information access for study teams with the introduction of Sofia, an AI-powered assistant currently utilized within Suvoda IRT. This platform aims to enhance user experiences by providing rapid, clear answers without navigating through complex steps. By embedding privacy controls and role-based access, Sofia promotes effective day-to-day decision-making for study teams while maintaining data security and the integrity of trials.

Acknowledging Innovation

Suvoda's progressive approach received notable recognition in 2025, including a new patent for its platform architecture, bringing its total to five patents. Moreover, Everest Group recognized Suvoda as a leader in its RTSM PEAK Matrix® evaluation. Throughout its portfolio, the enhancements introduced by Suvoda aim to optimize transparency, data quality, and usability, reflecting its commitment to practical innovation that supports real-world testing operations.

Positioned for Continued Growth into 2026

As the company looks ahead to 2026, it anticipates continued strong growth, as pharmaceutical sponsors and CROs increasingly seek unified platforms that reduce clinical trial complexity while supporting exceptional site and patient experiences. "In 2025, we did not just merge two companies, but unified our technologies, our personnel, and our mission," noted Wanninayake. "This foundation positions us to provide even greater value in 2026 and beyond. We are equipped to assist sponsors and sites in addressing more clinical trial needs while helping patients navigate their studies with ease and confidence."

About Suvoda

Suvoda is a global clinical trial technology company offering a leading real-time software platform that empowers sponsors and CROs to make informed decisions while allowing sites and patients to operate with peace of mind and control. Suvoda provides interconnected, action-oriented software solutions alongside industry-leading services and support to ensure that even in the most urgent and critical moments, life-changing studies continue to progress. Based in the Philadelphia suburbs, Suvoda operates additional offices in Portland, Oregon; Barcelona, Spain; Bucharest and Iasi, Romania; and Tokyo, Japan. The company consistently maintains customer satisfaction rates exceeding industry technological averages, contributing to its selection by trial sponsors and CROs to support over 2,000 trials in more than 95 countries. Having recently merged with Greenphire, a leading provider of financial management and patient support tools for clinical trials, Suvoda is poised for significant advancements as the journey into 2026 unfolds. For more information, visit suvoda.com and follow Suvoda on LinkedIn.